Roles of free fatty acid macrophage mediated killing of mycobacteria
Roles of free fatty acid macrophage mediated killing of mycobacteria
批准号:
13670272
负责人:
TOMIOKA Haruaki
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We previously reported that reactive nitrogen intermediates and free fatty acid (FFA) play important roles in the expression of the activity of mouse peritoneal macrophages (Mφs) against Mycobacterium tuberculosis (MTB) and M. avium complex (MAC). In the present study, we examined the roles of phospholipase A_2 (PLA_2) which specifically releases arachidnic acid (AA) from membrane phospholipid in Mφantimycobacterial activity, and obtained the following results. (1) The intracellular growth of MTB residing in IFN-γ-activated Mφs was accelerated by the quinacrine (PLA_2 inhibitor) and a-TFMK (cPLA_2 inhibitor) (2) The radioactivity of MTB organisms, which were recovered from ^3H-AA loaded Mφs, was progressively increased during Mφ cultivation after MTB infection. Such a phenomenon was blocked when Mφs were treated quinacrine or a-TFMK, indicating that AA translocated to MTB within phagosome in a cPLA_2-dependent fashion. (3) The expression of cPLA_2 and iNO5 mRNAs was increased in IFN-γ- activated Mφ, this is not the case for sPLA_2 mRNA. (4) Fluorescence microscopy on infected Mφs stained with anti cPLA_2 antibody and pyrene labelled cPLA_2 substrates demonstrated that cPLA_2 translocated to mycobacterial organisms within the phagosomes of the Mφs. (5) In the case of mouse peritoneal Mφs, MAP kinase-dependent cPLA_2 phospholylation at the serine residues was observed in the early phase of Mφ cultivation after MTB infection, gradually increased at least for 48 h. On the other hand, constitutive phospholylation of cPLA_2 was observed in RAW Mφs regard less of MTB infection. These findings indicate that cPLA_2 plays important roles in the expression of antimicrobial activity of Mφs against MTB and MAC.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sato K, Tomioka H, Shimizu T, Gonda T, Ohta F, Sano C: "Type II alveolar cells roles in macrophage-mediated host innate resistance to pulumonary Mycobacterial infections by producing proinflammatory cytokines"The Journal of Infectious Diseases. 185. 1139-
Sato K、Tomioka H、Shimizu T、Gonda T、Ohta F、Sano C:“II 型肺泡细胞通过产生促炎细胞因子在巨噬细胞介导的宿主对肺部分枝杆菌感染的先天抵抗中发挥作用”《传染病杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
冨岡 治明: "結核 (光山 正雄 編):分担執筆"医薬ジャーナル社. 322-333 (2001)
富冈晴明:“结核病(三山正夫编辑):撰稿人”Iyaku Journalsha 322-333(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sato K, Akaki T, Shimizu T, Sano C, Ogasawara K, Tomioka H: "Invasion and intracellular growth of Mycobacterium avium complex adapted to intramacrophage enviroment within macrophages and type II alveolar epitherial cells"Kekkaku. 76(2). 54-57 (2001)
Sato K、Akaki T、Shimizu T、Sano C、Ogasawara K、Tomioka H:“适应巨噬细胞和 II 型肺泡上皮细胞内巨噬细胞内环境的鸟分枝杆菌复合体的侵袭和细胞内生长”Kekkaku。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sano C, Sano K, Sato K, Ogasawara K, Shimizu T, Tomioka H: "Effects of ATP on the in vivo and in vitro Antimicrobial activity of murine macrophages against Mycobacterium avium complex"Japanese J. Chemother. 50(12). 848-853 (2002)
Sano C、Sano K、Sato K、Ogasawara K、Shimizu T、Tomioka H:“ATP 对小鼠巨噬细胞体内和体外抗鸟分枝杆菌复合物抗菌活性的影响”Japan J. Chemother。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
佐藤 勝昌, 赤木 竜也, 清水 利朗, 冨岡 治朗 他: "抗酸菌のマクロファージ(Mφ)と肺胞上皮細胞への感染性と細胞内増殖性:Mφ内順化菌を用いての検討"結核. 76・2. 54-57 (2001)
Katsumasa Sato、Tatsuya Akagi、Toshiro Shimizu、Jiro Tomioka 等:“抗酸细菌对巨噬细胞(Mφ)和肺泡上皮细胞的感染性和细胞内增殖:使用 Mφ 适应细菌的研究”结核病 76・2。 -57 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 47 条
Development of new antituberculous drugs based on CoMFA 3D-QSAR analysis
-
批准号:23659506
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TOMIOKA Haruaki
-
依托单位:
Molecular biological study on macrophage antimicrobial mechanism based on phospholipase A_2
-
批准号:20591202
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:TOMIOKA Haruaki
-
依托单位:
Study of virulence and drug-susceptabiltly of MAC strains isolated from Japanese patients with the nodular-bronchiectasis type MAC disease
-
批准号:18590850
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:TOMIOKA Haruaki
-
依托单位:
Mechanisms of phospholipase A_2-dependent killing of microorganisms on macrophages
-
批准号:16590358
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:TOMIOKA Haruaki
-
依托单位:
STUDIES ON THE MECHANISMS FOR EXPRESSION OF THE SUPPRESSOR ACTIVITY BY MYCOBACTERIUM AVIUM COMPLEX-INDUCED IMMUNOSUPPRESSIVE MACROPHAGES
-
批准号:10670255
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1998
-
负责人:TOMIOKA Haruaki
-
依托单位:
Study on the roles of immunosuppressive cytokines in the establishment and progression of mycobacterial infections
-
批准号:07670310
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1995
-
负责人:TOMIOKA Haruaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位:
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
-
批准号:82370923
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张文杰
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
-
批准号:82372160
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈峰
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
-
批准号:81102247
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:丁晨光
-
依托单位:
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
-
批准号:81070041
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:甘辉立
-
依托单位: